Issue: Sep 30, 2010
On July 15, 1962, a Washington Post story, ‘Heroine of FDA keeps bad drug off market,’ shocked Americans. The heroine in question was Frances Oldham Kelsey. She had joined the US Food and Drug Administration two years earlier as a drug application investigator. With her expertise in pharmacology, she was the obvious choice to test the veracity of an application for a “harmless” sedative that was already being sold in 46 countries. The drug, Kevadon, was one of the trade names of thalidomide.
Yes, thats indeed a good editorial. But i believe, initiatives are good till they kick start and make news, but what is...
Land and water management cannot be left to a bureaucracy, members of whom may not be posted in a place long enough to...